Full-Time
Posted on 10/3/2025
Cloud-based healthcare data analytics and BI
No salary listed
Company Historically Provides H1B Sponsorship
Bowie, MD, USA
In Person
Inovalon provides a cloud-based platform that helps healthcare organizations turn data into actionable insights to improve patient care and operating performance. Its platform integrates real-time data from providers, payers, and life sciences, offering more than 100 analytics and BI tools for areas like revenue cycle management, care quality, and workforce management, accessed via subscriptions, with consulting services to maximize value. The company differentiates itself by offering a single, cloud-based platform with national-scale connectivity and real-time data access across multiple stakeholders, enabling end-to-end data-driven workflows. Its goal is to improve clinical outcomes, operational efficiency, and financial performance through data-driven decision support.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Bowie, Maryland
Founded
1997
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
401(k) Company Match
Paid Vacation
Hybrid Work Options
DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. March 11, 2026 Seasoned pharmacy and healthcare technology leader to oversee clinical strategy, biostatistics and scientific innovation JUPITER, FL- March 12, 2026 - DoseMe, a global leader in model-informed precision dosing (MIPD) software, today announced the appointment of Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. In this role, Malone will lead the company's clinical and scientific initiatives, including oversight of biostatistics, clinical content development, and alignment of scientific strategy with DoseMe's broader growth objectives, including integration of newly acquired capabilities from Firstline. The combined platform of DoseMe and Firstline unifies evidence-based antimicrobial selection with Bayesian model-informed precision dosing within a single, streamlined clinical workflow. Together, the integrated solution enables health systems to align stewardship strategy, prescribing guidance, and individualized dosing optimization to improve outcomes, reduce resistance risk, and enhance operational efficiency. "Richard's unique combination of frontline clinical expertise, operational leadership, and healthcare technology experience strengthens DoseMe's ability to deliver scientifically rigorous, clinically practical precision dosing solutions," said John Hardesky, CEO of DoseMe. "As we expand our platform with the integration of Firstline's clinical decision support capabilities, his leadership positions us to further advance Bayesian modeling and unified antimicrobial stewardship solutions for health systems worldwide." Malone brings more than 30 years of leadership experience spanning hospital pharmacy operations, investigational drug services, healthcare software, and executive sales leadership. Malone will manage the team of biostatisticians responsible for building and advancing clinical models within the DoseMe platform and serve as the company liaison to the DoseMe Clinical Advisory Board. He will also play a key role in ensuring alignment between scientific innovation and the company's strategic roadmap. "I'm excited to join DoseMe at a time when precision dosing and model-informed drug therapy are becoming central to modern antimicrobial stewardship and patient safety," said Malone. "I look forward to strengthening the company's scientific foundation while supporting scalable growth." Most recently, Malone served as Vice President, Sales at Inovalon, where he led the Care Management business unit's national sales operations. Under his leadership, the team accelerated growth to $3.6 million in new annual contract value in 2024 and achieved greater than 100% net revenue retention, followed by 140% year-over-year ARR growth in the first half of 2025. Prior to Inovalon, Malone was president of McCreadie Group LLC, a healthcare software company acquired by Cordance Operations. During his tenure, the organization achieved 24% year-over-year growth and 28% EBITDA, while expanding its SaaS solutions supporting pharmaceutical research sites and pharmacy residency programs. Malone also brings deep academic medical center experience. He served for nearly a decade as Program Director of the Investigational Drug Service at Vanderbilt University Medical Center, where he led consolidation and expansion of research pharmacy services across the enterprise, improved quality metrics to over 99%, and transitioned the department to a positive operating margin within 12 months. Earlier in his career, he held executive pharmacy leadership roles including Director of Pharmacy at Centennial Medical Center and Maury Regional Medical Center, as well as Corporate Director of Pharmacy Operations for Vanguard Health Systems, overseeing pharmacy strategy across a 25-hospital system. Malone earned his Doctor of Pharmacy with honors from the University of Tennessee College of Pharmacy and a Master of Science in Health Care Administration from the University of Maryland University College. He completed his Pharmacy Practice Residency at Saint Thomas Hospital in Nashville, Tennessee. About DoseMe DoseMe is the provider of Firstline and DoseMeRx clinical decision support technologies that enable proactive, personalized care. Firstline is a mobile-first platform making treatment guidance accessible to every clinician, anywhere. DoseMeRx delivers clinically validated PK/PD models to individualize precision dosing in seconds. DoseMe's evidence-based clinical intelligence helps reduce adverse drug events, antibiotic overuse, improved adherence to stewardship guidance, and provides clinicians a clear path to optimal care. For more information and real-world success stories, visit https://doseme-rx.com/success-stories * News briefs American Journal of Health-System Pharmacy, 2021 * ASHP Executive Forums on Cold Chain Management of Pharmaceuticals in Health Systems American Journal of Health-System Pharmacy * SITC Appoints James Gulley as Vice President ASH Clinical News, 2022 * ASHP Distinguished Leadership Award Kate Traynor, American Journal of Health-System Pharmacy, 2022 * Appointment American Journal of Health-System Pharmacy, 2021
SSM Health Good Samaritan Hospital named to inaugural Forbes Top Hospitals 2026 lists. * Posted By: Withers Syndication * February 5, 2026 @ 12:43 pm * Local News MT. VERNON - SSM Health Good Samaritan Hospital in Mt. Vernon has been recognized as one of the top-performing hospitals in the nation on the inaugural Forbes Top Hospitals 2026 list. This prestigious ranking evaluates hospitals based on excellence in patient care, clinical outcomes, value, and patient experience. SSM Health Good Samaritan Hospital is proud to be among the 10 SSM Health hospitals recognized this year for their outstanding quality and compassionate care. This first-of-its-kind list was created to help consumers navigate the increasingly complex healthcare landscape. Forbes partnered with Inovalon, a leading healthcare analytics company, and collaborated with experts in medicine, health policy, and patient advocacy to develop a rigorous, data-driven evaluation for the rankings. This recognition reflects the commitment of SSM Health physicians, nurses, caregivers, and support staff who prioritize patient care daily, delivering exceptional, patient-centered services to the communities they serve. "Being included on this list is an extraordinary honor and a true reflection of the commitment our team demonstrates every day," stated Damon Harbison, President of SSM Health Good Samaritan Hospital, SSM Health St. Mary's Hospital, and SSM Health Rural Health Network in Illinois. "We are extremely proud of what this achievement means for our patients and the communities of southern Illinois."
Inovalon has launched Clinical Trial Eligibility Screener, a new API service designed to accelerate clinical trial recruitment by evaluating patient eligibility against study criteria in real time using longitudinal medical data. The service addresses persistent recruitment challenges in clinical research, where 86% of sites miss enrolment targets and up to half enrol one or no patients. Traditional pre-screening methods like telephone interviews often prove inefficient when patients are ultimately ineligible. The API uses natural language processing to interpret trial eligibility criteria and returns a pass, fail or inconclusive status for each requirement. This enables sponsors, clinical research organisations and recruitment vendors to quickly verify patient-reported medical histories and prioritise likely-eligible participants, reducing time and resources spent on ineligible candidates. Inovalon's platform draws on data from over 95 billion medical events across 451 million unique lives.
- Inovalon, a provider of solutions that empower data-driven healthcare, has announced a new collaboration with Google Cloud to develop an AI-enabled solution designed to address administrative burdens in the healthcare industry.
Inovalon launches AI solution in partnership with AWS to help Health Plans meet new RADV Audit requirements.